MedPath

Metcela, Inc.

Metcela, Inc. logo
🇯🇵Japan
Ownership
Holding
Established
2016-03-09
Employees
11
Market Cap
-
Website
http://www.metcela.com

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 3
3 (100.0%)

Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)

Phase 3
Recruiting
Conditions
Single Ventricle
Hypoplastic Left Heart Syndrome
First Posted Date
2016-05-25
Last Posted Date
2022-09-30
Lead Sponsor
Metcela Inc.
Target Recruit Count
40
Registration Number
NCT02781922
Locations
🇯🇵

Kanagawa Children's Medical Center, Kanagawa, Japan

🇯🇵

Okayama University Hospital, Okayama, Japan

🇯🇵

Shizuoka Children's Hospital, Shizuoka, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.